(Updated - January 5, 2026 7:35 AM EST)

Guggenheim analyst Debjit Chattopadhyay lowered the price target on Ultragenyx Pharma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE